Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Efficacy of oral immunotherapy in a case of metastatic breast cancer

Joint Event on 5th Edition of International Conference on Clinical Oncology and Molecular Diagnostics & 5th World Congress on Medical Imaging & Clinical Research
June 17-18, 2019 Rome, Italy

Tarang Krishna

Dr. Krishna��?s Cancer Healer Center, India

Scientific Tracks Abstracts: Arch Cancer Res


Breast cancer is one of the most common cancers in women. World Health Organization estimated the number of diagnosed breast cancer cases at approximately 2.1 million in 2018. This equals to about 11.6% of the total cancer incidence burden. Globally, the incidence rates of breast cancer are much higher as compared to other cancers. Such high prevalence of breast cancer calls for an effective treatment that is able to resolve the condition permanently. Although the best form of resolution is early diagnosis but an assured treatment should be sought as most of the cases get detected in advanced stages. Most of the patients undergo surgery which is coupled with either adjuvant or neoadjuvant chemotherapy and in some cases radiotherapy. The potential side effects of chemotherapy and radiotherapy make them a non viable option. The treatments of hormone therapy and targeted therapy are also not devoid of side effects. The treatment should be such, which relieves the ailment of the patient rather than augmenting it. Another form of treatment that has emerged to treat various forms of cancer including breast cancer is immunotherapy and it is still in the stage of clinical trials. Many studies have been conducted in relation to the treatment of metastatic breast cancer with immunotherapy but the possibility of emergence of alternate effects has also not been entirely ruled out. This case report aims to establish the efficacy of oral immunotherapy treatment in a patient of metastatic breast cancer in terms of the following: 1) Relieving the patient of her presenting complaints. 2) Removing the evidence of the disease completely from the body without any side effects. 3) Ruling out relapse of the disease. 4) Ensuring a normal life to the patient.

Biography :

Dr. Tarang Krishna is a distinguished and acclaimed physician who has made immense contribution in the field of cancer treatment. A well known and a fabled personality in healthcare, Dr. Tarang Krishna has successfully treated thousands of patients over a span of 18 years. Dr. Krishna completed his MD and thereafter went on to do his PhD from University of London. His aim is to promote and spread the awareness of the benefits of immunotherapy to maximum number of people. He has been appreciated and awarded several times by the Government of India as well as by International Organizations.